Company Filing History:
Years Active: 1981-1988
Title: Minoru Yamamoto: Innovator in CNS Active Compounds
Introduction
Minoru Yamamoto is a distinguished inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with strong central nervous system (CNS) activity. With a total of 6 patents to his name, Yamamoto's work has the potential to impact the treatment of various neurological conditions.
Latest Patents
Yamamoto's latest patents include innovative CNS active substituted azetidinone compounds. These compounds are characterized by a specific formula that allows for various substitutions, including lower alkyl groups and functional groups such as azido, amino, and mercapto. The compounds are designed to exhibit strong CNS action, making them useful in treating disturbances of consciousness associated with conditions like schizophrenia and head injuries. Another notable patent is the 4-substituted-2-azetidinone compound, which also demonstrates strong CNS activity and is aimed at improving memory loss and hypobulia.
Career Highlights
Minoru Yamamoto is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of CNS-related disorders.
Collaborations
Yamamoto has collaborated with notable colleagues such as Toshinari Tamura and Hidenori Iwamoto, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Minoru Yamamoto's contributions to the field of CNS active compounds highlight his role as a leading inventor in pharmaceutical chemistry. His innovative patents and collaborations reflect a commitment to improving healthcare outcomes for individuals with neurological conditions.